Abstract: Bacillus strain compositions and methods for reducing growth of one or more mastitis-causing organisms and/or reducing a symptom, sign, or occurrence of mastitis in animals are provided. The Bacillus strain composition can comprise a bacterial cell, a spore, a forespore, and/or a combination of cells, spores, and/or forespores of Bacillus subtilis 839, Bacillus subtilis 4976, and/or an active variant thereof. Compositions and methods provided herein can be applied to beddings of animals, such as dairy cows, and can reduce symptoms, signs, and/or occurrences of mastitis (e.g., environmental mastitis) in the animals and/or reduce somatic cell count in the milk produced by the animals. Beddings for animals comprising the Bacillus strain compositions provided herein in an effective amount to reduce growth of one or more mastitis-causing organisms are also provided.

Abstract: An apparatus for helping to protect an occupant of a vehicle in the event of a far-side collision in which the vehicle is impacted on a side opposite the seat in which the occupant is seated includes a curtain airbag configured to inflate and deploy from a roof of the vehicle in response to a far-side collision. The curtain airbag has an inflated and deployed condition in which the curtain airbag is positioned inboard of the vehicle occupant.

Abstract: A vehicle safety system for helping to protect an occupant of a vehicle seat includes a seatbelt extensible around the occupant to help restrain the occupant in the vehicle seat. The seatbelt includes a lap belt configured to extend across the occupant at the hips. An airbag is secured to the lap belt and configured to inflate and deploy upward from the lap belt to a deployed position in front of the occupant. The system is configured to adjust the deployed position of the airbag in response to the position of the occupant.

Abstract: An apparatus for helping to protect an occupant of a vehicle in the event of a far-side collision in which the vehicle is impacted on a side opposite the seat in which the occupant is seated includes a curtain airbag configured to inflate and deploy from a roof of the vehicle in response to a far-side collision. The curtain airbag has an inflated and deployed condition in which the curtain airbag is positioned inboard of the vehicle occupant.

Abstract: Bacillus strains, compositions and methods are disclosed for reducing growth of microorganisms in a feed. Bacillus strains, compositions and methods are disclosed for providing beneficial effects to animals, including but not limited to increasing performance of the animal.

Abstract: Disclosed are methods of administering one or more Bacillus strains to poultry. The Bacillus strains improve bacterial homeostasis in the gastrointestinal tract by inhibiting bacterial pathogens such as E. coli and Clostridium. Administering the Bacillus strains also improves performance such as weight gain and feed conversion. Useful combinations of Bacillus strains and methods of using one or more Bacillus strains are also provided.

Abstract: A vehicle safety system for helping to protect an occupant of a vehicle seat includes a seatbelt extensible around the occupant to help restrain the occupant in the vehicle seat. The seatbelt includes a lap belt configured to extend across the occupant at the hips. An airbag is secured to the lap belt and configured to inflate and deploy upward from the lap belt to a deployed position in front of the occupant. The system is configured to adjust the deployed position of the airbag in response to the position of the occupant.

Abstract: This disclosure relates generally to a microbial treatment for poultry. More particularly, the disclosure relates to a direct fed microbial composition including one or more lactic acid bacteria strains in combination with one or more Bacillus bacteria strains configured to inhibit gastrointestinal pathogens in a bird. A method of use is also disclosed herein.

Abstract: Bacillus strains, compositions and methods are disclosed for reducing growth of microorganisms in a feed. Bacillus strains, compositions and methods are disclosed for providing beneficial effects to animals, including but not limited to increasing performance of the animal.

Abstract: Bacillus strains, compositions and methods are disclosed for reducing growth of microorganisms in a feed. Bacillus strains, compositions and methods are disclosed for providing beneficial effects to animals, including but not limited to increasing performance of the animal.

Abstract: Disclosed are methods of administering one or more Bacillus strains to poultry. The Bacillus strains improve bacterial homeostasis in the gastrointestinal tract by inhibiting bacterial pathogens such as E. coli and Clostridium. Administering the Bacillus strains also improves performance such as weight gain and feed conversion. Useful combinations of Bacillus strains and methods of using one or more Bacillus strains are also provided.

Abstract: Disclosed are methods of administering one or more Bacillus strains to poultry. The Bacillus strains improve bacterial homeostasis in the gastrointestinal tract by inhibiting bacterial pathogens such as E. coli and Clostridium. Administering the Bacillus strains also improves performance such as weight gain and feed conversion. Useful combinations of Bacillus strains and methods of using one or more Bacillus strains are also provided.

Abstract: Bacillus strains, compositions and methods are disclosed for reducing growth of microorganisms in a feed. Bacillus strains, compositions and methods are disclosed for providing beneficial effects to animals, including but not limited to increasing performance of the animal.

Abstract: This disclosure relates generally to a microbial treatment for poultry. More particularly, the disclosure relates to a direct fed microbial composition including one or more lactic acid bacteria strains in combination with one or more Bacillus bacteria strains configured to inhibit gastrointestinal pathogens in a bird. A method of use is also disclosed herein.

Abstract: This invention relates to a novel strain of Megasphaera elsdenii and its uses. This invention further relates to preparations and methods incorporating such strain. This invention also relates to feedstuffs for ruminants and a preparation and method for the prevention and treatment of lactic acidosis in ruminants. This invention even further relates to a method of isolating a biologically pure culture of a superior ruminal microorganism in a relatively shorter time period than conventional methods. This invention yet further relates to a method of achieving any one or more of the following improvements in ruminants namely increased milk production; improved feedlot performance; improved growth rate; decrease in finishing time; lower digestive morbidity and mortality; lower incidence of lactic acidosis and related diseases; improved feed conversion efficiency; decrease in roughage content in feeds; and capability to feed on relatively higher concentrate diets.